Novel Cytokine Inhibitors:
Cytokines have become established as key mediators of the signs and symptoms of inflammatory diseases such as arthritis, dermatitis, asthma and multiple sclerosis. Furthermore, they are involved in the cascade of events leading to cardiovascular shock and are major regulators of the function of immu...
Gespeichert in:
Weitere Verfasser: | , |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Basel
Birkhäuser Basel
2000
|
Schriftenreihe: | Progress in Inflammation Research
|
Schlagworte: | |
Online-Zugang: | UBR01 Volltext |
Zusammenfassung: | Cytokines have become established as key mediators of the signs and symptoms of inflammatory diseases such as arthritis, dermatitis, asthma and multiple sclerosis. Furthermore, they are involved in the cascade of events leading to cardiovascular shock and are major regulators of the function of immune cells. This book reviews recent advances in the development of new anti-inflammatory drugs. It addresses different therapeutic intervention possibilities for new drugs, such as the cellular source of cytokines, specific receptors which induce cytokine synthesis, intracellular regulators of cytokine gene induction and expression, secretion and activation of cytokines, cytokine receptors and signalling pathways from these receptors. Accordingly, experts were drawn from different backgrounds including academic research institutes, the pharmaceutical industry and clinical pharmacology. In each area, the opportunities for drug development are highlighted and, where possible, clinical data is reviewed |
Beschreibung: | 1 Online-Ressource (VIII, 270 p) |
ISBN: | 9783034884501 |
DOI: | 10.1007/978-3-0348-8450-1 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV046146312 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 190905s2000 |||| o||u| ||||||eng d | ||
020 | |a 9783034884501 |9 978-3-0348-8450-1 | ||
024 | 7 | |a 10.1007/978-3-0348-8450-1 |2 doi | |
035 | |a (ZDB-2-SME)978-3-0348-8450-1 | ||
035 | |a (OCoLC)1119015700 | ||
035 | |a (DE-599)BVBBV046146312 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-355 | ||
082 | 0 | |a 616.079 |2 23 | |
084 | |a WF 9910 |0 (DE-625)148480: |2 rvk | ||
084 | |a XD 3200 |0 (DE-625)152553:12905 |2 rvk | ||
084 | |a XG 4300 |0 (DE-625)152801:12905 |2 rvk | ||
245 | 1 | 0 | |a Novel Cytokine Inhibitors |c edited by Gerry A. Higgs, Brian Henderson |
264 | 1 | |a Basel |b Birkhäuser Basel |c 2000 | |
300 | |a 1 Online-Ressource (VIII, 270 p) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a Progress in Inflammation Research | |
520 | |a Cytokines have become established as key mediators of the signs and symptoms of inflammatory diseases such as arthritis, dermatitis, asthma and multiple sclerosis. Furthermore, they are involved in the cascade of events leading to cardiovascular shock and are major regulators of the function of immune cells. This book reviews recent advances in the development of new anti-inflammatory drugs. It addresses different therapeutic intervention possibilities for new drugs, such as the cellular source of cytokines, specific receptors which induce cytokine synthesis, intracellular regulators of cytokine gene induction and expression, secretion and activation of cytokines, cytokine receptors and signalling pathways from these receptors. Accordingly, experts were drawn from different backgrounds including academic research institutes, the pharmaceutical industry and clinical pharmacology. In each area, the opportunities for drug development are highlighted and, where possible, clinical data is reviewed | ||
650 | 4 | |a Immunology | |
650 | 4 | |a Pharmacology/Toxicology | |
650 | 4 | |a Medicine/Public Health, general | |
650 | 4 | |a Cell Biology | |
650 | 4 | |a Immunology | |
650 | 4 | |a Toxicology | |
650 | 4 | |a Medicine | |
650 | 4 | |a Cytology | |
650 | 0 | 7 | |a Cytokine |0 (DE-588)4205701-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Inhibitor |0 (DE-588)4027007-5 |2 gnd |9 rswk-swf |
689 | 0 | 0 | |a Cytokine |0 (DE-588)4205701-2 |D s |
689 | 0 | 1 | |a Inhibitor |0 (DE-588)4027007-5 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Higgs, Gerry A. |4 edt | |
700 | 1 | |a Henderson, Brian |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783764359423 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783034895729 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783034884518 |
856 | 4 | 0 | |u https://doi.org/10.1007/978-3-0348-8450-1 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-2-SME | ||
940 | 1 | |q ZDB-2-SME_1990/2004 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-031526497 | ||
966 | e | |u https://doi.org/10.1007/978-3-0348-8450-1 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804180484132962304 |
---|---|
any_adam_object | |
author2 | Higgs, Gerry A. Henderson, Brian |
author2_role | edt edt |
author2_variant | g a h ga gah b h bh |
author_facet | Higgs, Gerry A. Henderson, Brian |
building | Verbundindex |
bvnumber | BV046146312 |
classification_rvk | WF 9910 XD 3200 XG 4300 |
collection | ZDB-2-SME |
ctrlnum | (ZDB-2-SME)978-3-0348-8450-1 (OCoLC)1119015700 (DE-599)BVBBV046146312 |
dewey-full | 616.079 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.079 |
dewey-search | 616.079 |
dewey-sort | 3616.079 |
dewey-tens | 610 - Medicine and health |
discipline | Biologie Medizin |
doi_str_mv | 10.1007/978-3-0348-8450-1 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03083nmm a2200601zc 4500</leader><controlfield tag="001">BV046146312</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s2000 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783034884501</subfield><subfield code="9">978-3-0348-8450-1</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-0348-8450-1</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-3-0348-8450-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119015700</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046146312</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.079</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">WF 9910</subfield><subfield code="0">(DE-625)148480:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XD 3200</subfield><subfield code="0">(DE-625)152553:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XG 4300</subfield><subfield code="0">(DE-625)152801:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Novel Cytokine Inhibitors</subfield><subfield code="c">edited by Gerry A. Higgs, Brian Henderson</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel</subfield><subfield code="b">Birkhäuser Basel</subfield><subfield code="c">2000</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (VIII, 270 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Progress in Inflammation Research</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Cytokines have become established as key mediators of the signs and symptoms of inflammatory diseases such as arthritis, dermatitis, asthma and multiple sclerosis. Furthermore, they are involved in the cascade of events leading to cardiovascular shock and are major regulators of the function of immune cells. This book reviews recent advances in the development of new anti-inflammatory drugs. It addresses different therapeutic intervention possibilities for new drugs, such as the cellular source of cytokines, specific receptors which induce cytokine synthesis, intracellular regulators of cytokine gene induction and expression, secretion and activation of cytokines, cytokine receptors and signalling pathways from these receptors. Accordingly, experts were drawn from different backgrounds including academic research institutes, the pharmaceutical industry and clinical pharmacology. In each area, the opportunities for drug development are highlighted and, where possible, clinical data is reviewed</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacology/Toxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine/Public Health, general</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cell Biology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Toxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cytology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytokine</subfield><subfield code="0">(DE-588)4205701-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Inhibitor</subfield><subfield code="0">(DE-588)4027007-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Cytokine</subfield><subfield code="0">(DE-588)4205701-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Inhibitor</subfield><subfield code="0">(DE-588)4027007-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Higgs, Gerry A.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Henderson, Brian</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783764359423</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783034895729</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783034884518</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-3-0348-8450-1</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031526497</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-0348-8450-1</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
id | DE-604.BV046146312 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T08:36:29Z |
institution | BVB |
isbn | 9783034884501 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031526497 |
oclc_num | 1119015700 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | 1 Online-Ressource (VIII, 270 p) |
psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
publishDate | 2000 |
publishDateSearch | 2000 |
publishDateSort | 2000 |
publisher | Birkhäuser Basel |
record_format | marc |
series2 | Progress in Inflammation Research |
spelling | Novel Cytokine Inhibitors edited by Gerry A. Higgs, Brian Henderson Basel Birkhäuser Basel 2000 1 Online-Ressource (VIII, 270 p) txt rdacontent c rdamedia cr rdacarrier Progress in Inflammation Research Cytokines have become established as key mediators of the signs and symptoms of inflammatory diseases such as arthritis, dermatitis, asthma and multiple sclerosis. Furthermore, they are involved in the cascade of events leading to cardiovascular shock and are major regulators of the function of immune cells. This book reviews recent advances in the development of new anti-inflammatory drugs. It addresses different therapeutic intervention possibilities for new drugs, such as the cellular source of cytokines, specific receptors which induce cytokine synthesis, intracellular regulators of cytokine gene induction and expression, secretion and activation of cytokines, cytokine receptors and signalling pathways from these receptors. Accordingly, experts were drawn from different backgrounds including academic research institutes, the pharmaceutical industry and clinical pharmacology. In each area, the opportunities for drug development are highlighted and, where possible, clinical data is reviewed Immunology Pharmacology/Toxicology Medicine/Public Health, general Cell Biology Toxicology Medicine Cytology Cytokine (DE-588)4205701-2 gnd rswk-swf Inhibitor (DE-588)4027007-5 gnd rswk-swf Cytokine (DE-588)4205701-2 s Inhibitor (DE-588)4027007-5 s DE-604 Higgs, Gerry A. edt Henderson, Brian edt Erscheint auch als Druck-Ausgabe 9783764359423 Erscheint auch als Druck-Ausgabe 9783034895729 Erscheint auch als Druck-Ausgabe 9783034884518 https://doi.org/10.1007/978-3-0348-8450-1 Verlag URL des Erstveröffentlichers Volltext |
spellingShingle | Novel Cytokine Inhibitors Immunology Pharmacology/Toxicology Medicine/Public Health, general Cell Biology Toxicology Medicine Cytology Cytokine (DE-588)4205701-2 gnd Inhibitor (DE-588)4027007-5 gnd |
subject_GND | (DE-588)4205701-2 (DE-588)4027007-5 |
title | Novel Cytokine Inhibitors |
title_auth | Novel Cytokine Inhibitors |
title_exact_search | Novel Cytokine Inhibitors |
title_full | Novel Cytokine Inhibitors edited by Gerry A. Higgs, Brian Henderson |
title_fullStr | Novel Cytokine Inhibitors edited by Gerry A. Higgs, Brian Henderson |
title_full_unstemmed | Novel Cytokine Inhibitors edited by Gerry A. Higgs, Brian Henderson |
title_short | Novel Cytokine Inhibitors |
title_sort | novel cytokine inhibitors |
topic | Immunology Pharmacology/Toxicology Medicine/Public Health, general Cell Biology Toxicology Medicine Cytology Cytokine (DE-588)4205701-2 gnd Inhibitor (DE-588)4027007-5 gnd |
topic_facet | Immunology Pharmacology/Toxicology Medicine/Public Health, general Cell Biology Toxicology Medicine Cytology Cytokine Inhibitor |
url | https://doi.org/10.1007/978-3-0348-8450-1 |
work_keys_str_mv | AT higgsgerrya novelcytokineinhibitors AT hendersonbrian novelcytokineinhibitors |